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This paper aims to examine the stability of lyophilized royal jelly by monitoring the content of its biologically active component, 
10-hydroxy-2-decenoic acid (10-HDA). Stability was monitored in the lyophilized royal jelly and in the finished products 
containing it. Analyses were performed using high performance liquid chromatography (HPLC) with diode array detector. 
Chromatographic conditions for HPLC with diode array detection were as followed: InterSustain® C18 column, 150 x 40 mm, 
5 μm; column temperature, 40 °C; mobile phase was a mixture of methanol: ultrapure water: phosphoric acid (250: 250: 1,25) 
with a flow rate of 1 mL/min. The detection wavelength was UV 210 nm. The amount of 10-HDA decreased regardless of storage 
conditions (room temperature and light protection), but the content of 10-HDA in any sample of the lyophilized royal jelly did 
not decline below the declared 3.5% during the shelf life. During the monitoring period, the analysed finished products also 
shown a decrease in the amount of 10-HDA, but if stored under recommended conditions, all analysed products contain the 
amount of 10-HDA in accordance with the declared value. 
 




Royal jelly has a wide range of positive effects on the 
human body making it one of the most valuable bee 
products. Bee glands, such as hypopharyngeal, 
mandibular, venom and wax, secrete numerous volatile 
and non-volatile components which are integral part of 
royal jelly, bee venom, and wax, the only three products 
that bees synthesize de novo (Erler and Moritz, 2016; 
Sabatini et al., 2009). The largest share in fresh royal jelly 
takes water, making 62.0 - 68.5% while the rest consists 
of proteins, lipids, carbohydrates, and to lesser extent 
vitamins and minerals (ISO, 2016). The main 
representatives of the proteins are the group of proteins 
called Major royal jelly proteins (MRJP), which make up 
the largest part of water-soluble proteins and it is 
assumed that they are responsible for the growth and 
development of the queen. A total of 26 amino acids 
were isolated and identified, of which 8 were essential 
for human organisms. Lipids are very important 
components of royal jelly of which more than 80% are 
free fatty acids while the rest are waxes, steroids, phenols 
and phospholipids. The most important representative of 
free fatty acids is 10-hydroxy-2-decenoic acid, which is 
characteristic of royal jelly, and as such is used as an 
indicator of quality and authenticity. The carbohydrate 
composition of royal jelly is similar to that of honey and 
is mostly composed of glucose and fructose, whose share 
reaches up to 90% of total carbohydrates, while the 
remaining share consists of ribose, trehalose, maltose and 
erlose. The most common vitamins are B vitamins, 
emphasizing pantothenic acid and niacin, whose shares 
are 0.095%, while the total share of vitamins A, C, D, 
and E is about 0.008%. The share of minerals ranges 
from 0.8% to 3%, and amongst them can be found K, Na, 
P, S, Ca, Al, Mg, Fe, Cu and Mn (Bogdanov, 2017; Xue 
et al., 2017; Ramadan and Al-Ghamdi, 2012). 
Fresh royal jelly is a yellowish-white, viscous substance 
with a sour-pungent odour and a sweet-sour taste. This 
highly beneficial blend has numerous biologically 
valuable components amongst which 10-HDA stands out 
as one of the most important (Bogdanov, 2017). 10-HDA 
has an effect on the activation and modulation of the 
immune system, acts on the production of collagen and 
has a mild estrogenic effect, antibacterial, anti-tumour, 
anti-inflammatory, anti-ulcer and anti-rheumatic effects. 
Due to the reasons above, royal jelly is often used as a 
dietary supplement and functional food, as well as an 
ingredient in cosmetic products (Bogdanov, 2017; 
Oršolić, 2013; Ramadan and Al-Ghamdi, 2012). 
Lyophilized royal jelly has the same biological 
characteristics as the fresh one due to process of 
lyophilization where the water is removed from the 
frozen product in the vacuum, which allows the retention 
of highly valuable components. Therefore, lyophilization 
is considered the best way to preserve the quality of royal 
jelly. During storage, it is extremely important to store 
lyophilized royal jelly in hermetically sealed containers 
due to its high hygroscopicity (Bogdanov, 2017; Krell, 
1996). The chemical composition of lyophilized royal 
jelly is not yet legally regulated, but there are 
recommendations given based on the work (Sabatini et 
al., 2009; Oršolić, 2013). Although Bogdanov (2017) 
states storing lyophilized royal jelly for a year at 
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refrigerator temperature (3 - 5 °C) or two years at freezer 
temperature (- 18 °C), manufacturers of lyophilized royal 
jelly recommend keeping it protected from light and high 
temperatures, with a shelf life of three years from the date 
of manufacture. 
The aim of this study was to examine the stability of 
lyophilized royal jelly and finished products containing 
it when stored at room temperature by monitoring the 
content of 10-HDA. 
 
Materials and methods 
 
Samples of lyophilized royal jelly 
 
Analyses were performed on 4 samples of lyophilized 
royal jelly. Stability monitoring of 10-HDA in 
lyophilized royal jelly samples was performed on 
samples purchased from two manufacturers in the period 
from 2011 till 2019. All samples originate from China 
and are submitted with the appropriate documentation or 
the certificate of analysis. The samples were stored 
protected from the light in a constant temperature room 
(22 ± 1.5 °C) with controlled content of the moisture in 
the air (47 ± 3 %), in accordance with the manufacturer's 
instructions. Sample 1, purchased from the first 
manufacturer, was submitted for analysis in 2011 and 
several analyses were performed, which were compared 
with the accompanying manufacturer's analysis 
certificate. The analyses were performed once a year in 
the period from 2013 till 2016. Another subsequent 
analysis was made in 2020 to confirm a further reduction 
in the share of 10-HDA. The remaining three samples 
were purchased from another manufacturer. They were 
analysed twice and the analytical reports were compared 
with the manufacturer’s analysis certificate. 
 
Samples of products with lyophilized royal jelly 
 
Samples of 9 finished products containing lyophilized 
royal jelly from the same manufacturer, which were 
stored according to the label, i.e. at the temperature up to 
25 °C, protected from light and heat sources, were 
analysed. The declared value of 10-HDA in the samples 
ranged from 5 to 20 mg of 10-HDA in 10 ml of the 
sample. The samples were divided into three groups and 
analysed at half-life, immediately after the expiration 




To prepare the mobile phase methanol HPLC grade 
(Merck, Germany), 85% phosphoric acid (Sigma-
Aldrich, USA) and ultra-pure water obtained by the 
Letzner water purification system (Hückeswagen, 
Germany) with an electrical conductivity of up to 0.04 
μS/cm and a 10-HDA standard (ChromaDex, USA) 




The analysis of lyophilized royal jelly samples and 
commercial samples containing it was performed on the 
Shimadzu HPLC system that includes LabSolution 
software, two quaternary pumps LC-20ADXR, a column 
chamber CTO-20AC, a diode array detector SPD-M20A 
and an autosampler SIL20-ACX. The separation of 
components was achieved on an InertSustain® C18 
column from GL Science, measuring 150 x 40 mm, filled 
with 5 μm particles. 
The mobile phase used for the analysis containing 
methanol, ultrapure water and phosphoric acid, prepared 
in a ratio of 250: 250: 1.25, was degassed with a vacuum 
pump before use. The flow of the mobile phase was 1 
ml/min at a column temperature of 40 °C with an 
injection volume of 5 μl. Spectrum recording was 
performed in the wavelength range from 190 to 370 nm, 
while detection was performed at a wavelength of 210 
nm. The identification of 10-HDA was performed by 
comparing the retention times of 10-HDA standard 
solution and sample solution (Fig. 1) and unquestionable 
identification was confirmed comparing the specific 
spectrum of 10-HDA standard solution and sample 
solution. 
The method (Garcia-Amoedo and Almeida-Muradian, 
2003) was modified to fit the samples for analysis and 
the device on which it is applied. For method validation, 
the latter procedures were performed following good 
laboratory practice (GLP) and good manufacturing 
practice (GMP). Linearity, which was tested in the 
working range from 0.13 to 100 µg/mL which proved to 
be satisfactory for the expected concentrations of 10-
HAD in royal jelly as raw material (1.26 - 2.25 % in fresh 
and 3.01 - 6.26 % in lyophilized royal jelly) and finished 
products containing it as an integral component. A limit 
of detection (LOD) was calculated based on signal-to-
noise ratio (3.3:1) and it was 0.048 µg/mL and a limit of 
quantification (LOQ), calculated based on signal-to-
noise ratio (10:1) (ICH, 2020), was 0.145 µg/mL. The 
precision of the method was tested through repeatability 
by successive measurements of three different 
concentrations in one day, giving a relative standard 
deviation (RSD) <0.46%. The average precision was 
determined by measuring three different concentrations 
over three days and RSD values obtained for peak area 
changes were <1.22%. The accuracy of the method was 
tested through analytical yield by analysis of three 
concentrations: 12.5, 50 and 100 µg/mL where analytical 
yields were obtained: 98.8%, 99.2% and 99.6%, 
respectively. The robustness of the method was tested by 
changing two experimental parameters (column 
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temperature and wavelength of detection), meeting the 
limits of acceptability for the tested changes (15%). 
Statistical analysis was performed using Microsoft Excel 




Fig. 1. Chromatogram of the lyophilized royal jelly solution 
 
 
Results and discussion 
 
Lyophilized royal jelly 
 
The sample of lyophilized royal jelly No. 1 was 
monitored from the date of production (December 
2011) to May 2020 (Fig. 2). This sample was supplied 
with an analytical certificate stating 4.2% of 10-HDA. 
During the shelf life, which was declared for 2 years 
from the date of manufacture, the share of 10-HDA 
decreased by 2.14%, and in the next year this value 
falls by 15.95% from the initial value and was at  
3.53% of the 10-HDA content, but thus still meets the 
recommendations for the share of 10-HDA in 
lyophilized royal jelly. The analysis conducted in the 
following years showed a further decrease in the 
share of 10-HDA in the examined sample. Over 10 
years, the analyses show a total decrease in the 
content of 10-HDA in the tested lyophilized royal 
jelly by 47.62% from the initial value declared on the 
manufacturer's certificate. Samples 2, 3 and 4 (Fig. 3) 
were purchased from another manufacturer and 
supplied with an analysis certificate stating the 
minimum share of 10-HDA of 5% and the validity 
period of three years from the date of manufacture. 
Over 1 year, the share of 10-HDA decreased by <1% 
and over 2 years to <20%, which is in line with the 





Fig. 2. Monitoring of the share of 10-HDA in sample 1 shown by years (*certified value) 





Fig. 3. Demonstration of the reduction of 10-HDA content in lyophilized royal jelly over 2 years 
 
 
Finished products containing lyophilized royal jelly 
 
Commercially available samples containing 
lyophilized royal jelly with a declaration stating the 
value of 10-HDA were analysed. The samples were 
divided into three groups. The declared value of 10-
HDA was compared with the analytically determined 
share of 10-HDA in the finished product with 
lyophilized royal jelly one year after production, 
right after the expiration date and one year after the 
expiration date. Samples 1, 2 and 3 are the products 
not yet expired. They show a higher value of 10-HDA 
than the declared one, on average 33 ± 10.70 %, 
which is acceptable considering the data indicating a 
decrease in the value of 10-HDA in the tested 
samples of lyophilized royal jelly. Products 4, 5 and 
6 that are near to the expiration date show the 
deviation of 11.69 ± 11.94 % from the declared 
values, which is within legal regulations. Products 7 
and 8 expired one year ago show a lower share of 10-
HDA than the declared values, 22.89 ± 18.72 %, 
while product 9 that was also tested one year after the 
expiration date does not show a significant decrease 




Fig. 4. 10-HDA concentration in commercially available products 
(  declared value,  analysis before expiration,  analysis after expiration,  analysis one year after expiration) 
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All of the above leads to the question of whether the 
obtained values of loss of 10-HDA content would be 
significantly lower if lyophilized royal jelly and 
finished products containing it were stored in different 
conditions (in a dark and cool place). Therefore, it 
would be desirable to continue this pilot study by 
conducting analyses for the quantitative determination 
of 10-HDA and to link the results to storage conditions. 
It would be necessary to store lyophilized royal jelly 
and finished products in precisely defined conditions 
of light, temperature (cold chain and room temperature) 





The data obtained from the conducted pilot study 
suggest stability of lyophilized royal jelly under the 
storage conditions specified by the manufacturer, i.e. 
at room temperature and protected from a light within 
the recommended shelf life. The analysis of finished 
products showed a higher value of 10-HDA than 
declared in half the shelf life, which is associated with 
meeting the requirements of the shelf life. According 
to the legislation, the declared content of 10-HDA 
must be satisfactory even at the end of the product's 
shelf life. Therefore, according to the data of reducing 
the value of 10-HDA in lyophilized royal jelly, it is 
necessary to increase the share of lyophilized royal 
jelly as a component of the finished product in order 
to comply with the regulations, which is (± 10% 10-
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